研究業績
Eur Urol. 89, 1 Suppl, S1-S2 (2026)
Prognostic significance of time-of-day administration (ToDA) of immune checkpoint inhibitor (ICI) in patients with metastatic renal cell carcinoma (mRCC) treated with first-line therapies
著者
Daiki Nakama, Masaharu Inoue, Takeshi Yuasa, David Maj, Martin Zarba, Parker Baumgarten, Naveen S Basappa, Ryosuke Oki, Tetsuya Urasaki, Noboru Numao, Junji Yonese, Fumiyasu Endo, Kazunori Hattori, Yuji Miura, Daniel Y C Heng, Kosuke Takemura.
カテゴリ
学会発表
